Response and remission after first-line corticosteroid therapy in primary immune thrombocytopenia
Background. Primary immune thrombocytopenia (ITP) is an acquired autoimmune disease characterised by an isolated thrombocytopenia of <100 × 109/L in the absence of identifiable secondary causes. Treatment is indicated when the platelet count is <20 - 30 × 109/L, but may be commenced at hi...
Saved in:
| Main Authors: | D Mapimhidze, J Bailly, K Brown, J Bailey, E Verburgh |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
South African Medical Association
2025-02-01
|
| Series: | South African Medical Journal |
| Subjects: | |
| Online Access: | https://samajournals.co.za/index.php/samj/article/view/2191 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Use of Immunosuppression, Romiplostim, and Splenectomy to Achieve Remission in a British Shorthair Cat With Primary Immune‐Mediated Thrombocytopenia
by: Josh M. Kennils, et al.
Published: (2025-07-01) -
Gut microbiota pattern in children and adolescents with newly diagnosed immune thrombocytopenia
by: Mohsen Elalfy, et al.
Published: (2025-07-01) -
The metabolism-immunity axis in Immune thrombocytopenia: from energy regulation to targeted therapy
by: Xin Zhou, et al.
Published: (2025-07-01) -
Correlation between Serum Levels of Some Immunological Biomarkers and Severity of Idiopathic Immune Thrombocytopenia
by: Ola A. Hashim, et al.
Published: (2025-06-01) -
Immune thrombocytopenia in Kabuki syndrome, a comparison with non-Kabuki cases in the UK paediatric ITP registry
by: Lianna Reynolds, et al.
Published: (2025-05-01)